BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22595649)

  • 1. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.
    Wang Y; Li L; Guo X; Jin X; Sun W; Zhang X; Xu RC
    Cytokine; 2012 Aug; 59(2):228-36. PubMed ID: 22595649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion.
    Wang Y; Xu RC; Zhang XL; Niu XL; Qu Y; Li LZ; Meng XY
    Cytokine; 2012 Jul; 59(1):145-55. PubMed ID: 22579115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.
    Ataie-Kachoie P; Morris DL; Pourgholami MH
    PLoS One; 2013; 8(4):e60817. PubMed ID: 23593315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y; Niu XL; Qu Y; Wu J; Zhu YQ; Sun WJ; Li LZ
    Cancer Lett; 2010 Sep; 295(1):110-23. PubMed ID: 20236757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M; Zhang X; Xu C
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y; Qu Y; Niu XL; Sun WJ; Zhang XL; Li LZ
    Cytokine; 2011 Nov; 56(2):365-75. PubMed ID: 21742513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.
    Sun W; Liu DB; Li WW; Zhang LL; Long GX; Wang JF; Mei Q; Hu GQ
    Int J Oncol; 2014 May; 44(5):1551-60. PubMed ID: 24603891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine production of interleukin-6 confers ovarian cancer cells resistance to tamoxifen via ER isoforms and SRC-1.
    Wang Y; Qu Y; Zhang XL; Xing J; Niu XL; Chen X; Li ZM
    Mol Cell Endocrinol; 2014 Feb; 382(2):791-803. PubMed ID: 24189439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer.
    Fanelli M; Camperchioli A; Petrella L; Petrillo M; Baranello C; Baccaro P; Paolillo C; Capoluongo E; Scambia G
    Int J Biol Markers; 2018 Jan; 33(1):124-131. PubMed ID: 29218693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.
    Chen Z; Fadiel A; Feng Y; Ohtani K; Rutherford T; Naftolin F
    Cancer; 2001 Dec; 92(12):3068-75. PubMed ID: 11753986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM; Hudson LG; Stack MS
    Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL6 induces TAM resistance via kinase-specific phosphorylation of ERα in OVCA cells.
    Wang Y; Niu XL; Guo XQ; Yang J; Li L; Qu Y; Xiu Hu C; Mao LQ; Wang D
    J Mol Endocrinol; 2015 Jun; 54(3):351-61. PubMed ID: 25943392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.
    Lo CW; Chen MW; Hsiao M; Wang S; Chen CA; Hsiao SM; Chang JS; Lai TC; Rose-John S; Kuo ML; Wei LH
    Cancer Res; 2011 Jan; 71(2):424-34. PubMed ID: 21123455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway.
    Sun X; Lin L; Chen Y; Liu T; Liu R; Wang Z; Mou K; Xu J; Li B; Song H
    Mol Med Rep; 2016 Apr; 13(4):3161-8. PubMed ID: 26935265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
    Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
    Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-106a regulates phosphatase and tensin homologue expression and promotes the proliferation and invasion of ovarian cancer cells.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Oncol Rep; 2016 Oct; 36(4):2135-41. PubMed ID: 27510094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F; Zhang X; Cao Y; Wang Y; Zhang X
    BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.